Literature DB >> 3244102

Uptake into mouse brain of four compounds present in the psychoactive beverage kava.

J Keledjian1, P H Duffield, D D Jamieson, R O Lidgard, A M Duffield.   

Abstract

A technique using gas chromatography-mass spectrometry and deuterated internal standards is described for the quantitation in brain tissue of four constituents of the intoxicating beverage kava. Dihydrokawain, kawain, desmethoxyyangonin, and yangonin were administered ip to mice at a dosage of 100 mg/kg. At specific time intervals (5, 15, 30, and 45 min), the mice were sacrificed and the brain concentrations of these four compounds determined. After 5 min, dihydrokawain and kawain attained maximum concentrations of 64.7 +/- 13.1 and 29.3 +/- 0.8 ng/mg wet brain tissue, respectively, and were rapidly eliminated. In contrast, desmethoxyyangonin and yangonin had poorly defined maxima corresponding to concentrations of 10.4 +/- 1.5 and 1.2 +/- 0.3 ng/mg wet brain tissue, respectively, and these compounds were more slowly eliminated from brain tissue. When crude kava resin was administered ip at a dosage of 120 mg/kg, the concentration in brain of kawain and yangonin markedly increased (2 and 20 times, respectively) relative to the values measured from their individual injection. In contrast, dihydrokawain and desmethoxyyangonin, after the administration of crude resin, remained at the percentage incorporation into brain tissue established for their individual ip injection.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3244102     DOI: 10.1002/jps.2600771203

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  9 in total

Review 1.  Therapeutic potential of kava in the treatment of anxiety disorders.

Authors:  Yadhu N Singh; Nirbhay N Singh
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

2.  Kavapyrone enriched extract from Piper methysticum as modulator of the GABA binding site in different regions of rat brain.

Authors:  A Jussofie; A Schmiz; C Hiemke
Journal:  Psychopharmacology (Berl)       Date:  1994-12       Impact factor: 4.530

3.  Extracts of kava (Piper methysticum) induce acute anxiolytic-like behavioral changes in mice.

Authors:  Kennon M Garrett; Garo Basmadjian; Ikhlas A Khan; Brian T Schaneberg; Thomas W Seale
Journal:  Psychopharmacology (Berl)       Date:  2003-07-04       Impact factor: 4.530

Review 4.  Activation of pregnane X receptor (PXR) and constitutive androstane receptor (CAR) by herbal medicines.

Authors:  Thomas K H Chang
Journal:  AAPS J       Date:  2009-08-18       Impact factor: 4.009

Review 5.  Toxicity of kava kava.

Authors:  Peter P Fu; Qingsu Xia; Lei Guo; Hongtao Yu; Po-Chuen Chan
Journal:  J Environ Sci Health C Environ Carcinog Ecotoxicol Rev       Date:  2008 Jan-Mar       Impact factor: 3.781

6.  A stable isotope dilution tandem mass spectrometry method of major kavalactones and its applications.

Authors:  Yi Wang; Shainnel O Eans; Heather M Stacy; Sreekanth C Narayanapillai; Abhisheak Sharma; Naomi Fujioka; Linda Haddad; Jay McLaughlin; Bonnie A Avery; Chengguo Xing
Journal:  PLoS One       Date:  2018-05-24       Impact factor: 3.240

Review 7.  An Updated Review on the Psychoactive, Toxic and Anticancer Properties of Kava.

Authors:  Rita B Soares; Ricardo Jorge Dinis-Oliveira; Nuno G Oliveira
Journal:  J Clin Med       Date:  2022-07-12       Impact factor: 4.964

8.  Boesenbergia rotunda: From Ethnomedicine to Drug Discovery.

Authors:  Tan Eng-Chong; Lee Yean-Kee; Chee Chin-Fei; Heh Choon-Han; Wong Sher-Ming; Christina Thio Li-Ping; Foo Gen-Teck; Norzulaani Khalid; Noorsaadah Abd Rahman; Saiful Anuar Karsani; Shatrah Othman; Rozana Othman; Rohana Yusof
Journal:  Evid Based Complement Alternat Med       Date:  2012-11-27       Impact factor: 2.629

9.  Kavain, the Major Constituent of the Anxiolytic Kava Extract, Potentiates GABAA Receptors: Functional Characteristics and Molecular Mechanism.

Authors:  Han Chow Chua; Emilie T H Christensen; Kirsten Hoestgaard-Jensen; Leonny Y Hartiadi; Iqbal Ramzan; Anders A Jensen; Nathan L Absalom; Mary Chebib
Journal:  PLoS One       Date:  2016-06-22       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.